Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
MONTE ROSA THERAPEUTICS INC
About GLUE
Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of novel and molecular glue degraders (MGDs). MGDs are small molecule drugs that employ the body’s natural protein destruction mechanisms to selectively degrade therapeutically relevant proteins. It has developed a proprietary and industry leading discovery engine, called Quantitative and Engineered Elimination of Neosubstrates (QuEEN) to enable its target centric MGD discovery and development approach and its rational design of MGD product candidates. Its product candidate, MRT-2359, is an orally bioavailable MGD targeting the translation termination factor protein GSPT1. MRT-2359 is in clinical development for potential use in MYC-driven tumors, including metastatic non-small cell lung cancer, small cell lung cancer, and neuroendocrine tumors. Its other product candidates include MRT-6160 and MRT-8102.
Find out what a historical investment in MONTE ROSA THERAPEUTICS INC would be worth today using our GLUE stock calculator.
Market Capitalisation
$1.53B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
926.13K
High today
$18.54
Low today
$17.93
Open price
$18.46
52-week high
$25.77
52-week low
$3.51
Ready to start your investing journey with Stake?
Open an accountHow do I buy GLUE shares in Australia?
Buying GLUE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in MONTE ROSA THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in GLUE
What is the ticker symbol of MONTE ROSA THERAPEUTICS INC?
The ticker symbol for MONTE ROSA THERAPEUTICS INC is GLUE.
How much is one share of GLUE?
One share of GLUE is valued at $18.09 as of 17 May 2026.
What is the market capitalisation of MONTE ROSA THERAPEUTICS INC GLUE?
As of 17 May 2026 MONTE ROSA THERAPEUTICS INC has a market cap of $1.53B.
What is the 52-week high for MONTE ROSA THERAPEUTICS INC stock?
The MONTE ROSA THERAPEUTICS INC 52-week high stock price is $25.77.
What is the 52-week low for MONTE ROSA THERAPEUTICS INC stock?
The MONTE ROSA THERAPEUTICS INC 52-week low stock price is $3.51.
Can I buy GLUE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GLUE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GLUE on Stake
- Buy GLUE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of GLUE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
GLUE related stocks